PARP10 and ovarian carcinoma: Regarding PARP10, its established role in cellular proliferation and carcinogenesis may suggest that PARP10 inhibitors could also be employed in cancer treatment, particularly breast and ovarian cancers, since PARP10 is specifically overexpressed in those tumors (37).